Renin-angiotensin system blockers in cardiac surgery

Journal of Critical Care

Volumn 30, Issue 3, 2015, Pages 613-618

  Mangieri, Antonio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

ACE inhibitors; Acute kidney injury; Atrial fibrillation; Cardiac surgery

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID BINDING PROTEIN; INTERLEUKIN 18; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACEBO; QUINAPRILAT; RAMIPRIL; ANGIOTENSIN RECEPTOR ANTAGONIST; MINERALOCORTICOID ANTAGONIST;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ANGIONEUROTIC EDEMA; ARTERIAL PRESSURE; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COUGHING; EXTRACELLULAR SPACE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; HYPOTENSION; INCIDENCE; KIDNEY PERFUSION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MITRAL VALVE PROLAPSE; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PERIOPERATIVE PERIOD; PROGNOSIS; PROPENSITY SCORE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK REDUCTION; SURVIVAL; THROMBOCYTE AGGREGATION; UNSTABLE ANGINA PECTORIS; VASOCONSTRICTION; VASODILATATION; VASOPLEGIA; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS;

ACUTE KIDNEY INJURY; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; BLOOD PRESSURE; CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR DISEASES; HEART FAILURE; HUMANS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84928591363     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2015.02.017     Document Type: Article

References (64)

1. Harskamp R.E., Walker P.F., Alexander J.H., Xian Y., Liberman H.A., de Winter R.J., et al. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. Am Heart J 2014, 168(4):471-478.
2. Calvert S., Shaw A. Perioperative acute kidney injury. Perioper Med (Lond) 2012, 1:1-6.
3. Rostagno C., Blanzola C., Pinelli F., Rossi A., Carone E., Stefàno P.L. Atrial fibrillation after isolated coronary surgery. Incidence, long-term effects and relation with operative technique. Heart Lung Vessel 2014, 6(3):171-179.
4. Kieser T.M., Rose M.S., Aluthman U., Montgomery M., Louie T., Belenkie I. Toward zero: deep sternal wound infection after 1001 consecutive coronary artery bypass procedures using arterial grafts: Implications for diabetic patients. J Thorac Cardiovasc Surg 2014, 148(5):1887-1895.
5. Kirklin J.K., Westaby S., Blackstone E.H., Kirklin J.W., Chenoweth D.E., Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983, 86(6):845-857.
6. Song S.W., Yi G., Lee S., Youn Y.N., Sul S.Y., Yoo K.J. Perioperative indicators of stress response and postoperative inflammatory complications in patients undergoing off-pump coronary artery bypass surgery: a prospective observational study. Circ J 2008, 72(12):1966-1974.
7. Kobzar G., Mardla V., Rätsep I., Samel N. Platelet activity before and after coronary artery bypass grafting. Platelets 2006, 17(5):289-291.
8. Sun J.Z., Cao L.H., Liu H. ACE inhibitors in cardiac surgery: current studies and controversies. Hypertens Res 2011, 34(1):15-22.
9. Ma T.K., Kam K.K., Yan B.P., Lam Y.Y. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 2010, 160(6):1273-1292.
10. Miller E.D., Ackerly J.A., Peach M.J. Blood pressure support during general anesthesia in renin-dependent state in the rat. Anesthesiology 1978, 48:404-408.
11. Behnia R., Molteni A., Igić R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des 2003, 9(9):763-776.
12. Durante A., Peretto G., Laricchia A., Ancona F., Spartera M., Mangieri A., et al. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr Pharm Des 2012, 18(7):981-1004.
13. Auron M., Harte B., Kumar A., Michota F. Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice. Postgrad Med J 2011, 87(1029):472-481.
14. Argenziano M., Chen J.M., Choudhri A.F., Cullinane S., Garfein E., Weinberg A.D., et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998, 116(6):973-980.
15. Bertrand M., Godet G., Meersschaert K., Brun L., Salcedo E., Coriat P. Should the angiotensin II antagonists be discontinued before surgery?. Anesth Analg 2001, 92:26-30.
16. Brown N.J., Agirbasli M.A., William G.H., Litchfield W.R., Vaughan D.E. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998, 32:965-971.
17. Miyazaki M., Sakonjo H., Takai S. Anti-atherosclerotic effects of an angiotensin-converting enzyme inhibitor and an angiotensin II antagonist in cynomolgus monkeys fed a high cholesterol diet. Br J Pharmacol 1999, 128:523-529.
18. Diet F., Pratt R.E., Berry G.J., Momose N., Gibbons G.H., Dzau V.J. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996, 94:2756-2767.
19. Lazar H.L., Bao Y., Rivers S., Colton T., Bernard S.A. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg 2001, 72:548-554.
20. Wang M., Zhang W., Zhou Y., Zhou X. Association between serum angiotensin-converting enzyme 2 levels and postoperative myocardial infarction following coronary artery bypass grafting. Exp Ther Med 2014, 7(6):1721-1727.
21. Lazar H.L., Bao Y., Rivers S., Bernard S. Pretreatment with angiotensin-converting inhibitors attenuates ischemic reperfusion injury during coronary revascularization. Ann Thorac Surg 2002, 73:1522-1527.
22. Lazar H.L. All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Circulation 2008, 117:6-8.
23. Oosterga M., Voors A.A., Pinto Y.M., Buikema H., Grandjean J.G., Kingma J.H., et al. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Am J Cardiol 2001, 87(5):542-546.
24. Kjøller-Hansen L., Steffensen R., Grande P. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES). Am Heart J 2004, 148(3):475-480.
25. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342(3):145-153.
26. Drenger B., Fontes M.L., Miao Y., Mathew J.P., Gozal Y., Aronson S., et al. Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. Circulation 2012, 126(3):261-269.
27. Benedetto U., Melina G., Capuano F., Comito C., Bianchini R., Simon C., et al. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery. J Cardiovasc Med (Hagerstown) 2008, 9(11):1098-1103.
28. Ouzounian M., Buth K.J., Valeeva L., Morton C.C., Hassan A., Ali I.S. Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery. Ann Thorac Surg 2012, 93(2):559-564.
29. Rouleau J.L., Warnica W.J., Baillot R., Block P.J., Chocron S., Johnstone D., et al. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery. Circulation 2008, 117(1):24-31.
30. Miceli A., Capoun R., Fino C., Narayan P., Bryan A.J., Angelini G.D., et al. Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2009, 54(19):1778-1784.
31. Durante A., Limite L.R., Peretto G., Laricchia A., Ancona F., Mangieri A., et al. Pharmacological and nonpharmacological treatment after cardiac surgery. Cardiol Rev 2014, 22(5):199-209.
32. Nomoto T., Nishina T., Tsuneyoshi H., Miwa S., Nishimura K., Komeda M. Effects of two inhibitors of renin-angiotensin system on attenuation of postoperative remodeling after left ventricular aneurysm repair in rats. J Card Surg 2003, 18(Suppl. 2):S61-S68.
33. Geirsson A., Singh M., Ali R., Abbas H., Li W., Sanchez J.A., et al. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers. Circulation 2012, 126(11 Suppl. 1):S189-S197.
34. Trevelyan J., Brull D.J., Needham E.W., Montgomery H.E., Morris A., Mattu R.K. Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene. Am J Cardiol 2004, 94(5):564-569.
35. Hata M., Sezai A., Niino T., Yoda M., Takayama T., Takemoto A., et al. Vascular protecting effect of angiotensin receptor blocker (ARB) on the radial artery graft. Ann Thorac Cardiovasc Surg 2008, 14(1):25-28.
36. Cheng X., Tong J., Hu Q., Chen S., Yin Y., Liu Z. Meta-analysis of the effects of preoperative renin-angiotensin system inhibitor therapy on major adverse cardiac events in patients undergoing cardiac surgery. Eur J Cardiothorac Surg 2014, 2014:132-137.
37. Karkouti K., Wijeysundera D.N., Yau T.M., Callum J.L., Cheng D.C., Crowther M., et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009, 119:495-502.
38. D'Onofrio A., Cruz D., Bolgan I., Auriemma S., Cresce G.D., Fabbri A., et al. RIFLE criteria for cardiac surgery-associated acute kidney injury: risk factors and outcomes. Congest Heart Fail 2010, 16(Suppl. 1):S32-S36.
39. Robert A.M., Kramer R.S., Dacey L.J., Charlesworth D.C., Leavitt B.J., Helm R.E., et al. Cardiac surgery-associated acute kidney injury: a comparison of two consensus criteria. Ann Thorac Surg 2010, 90:1939-1943.
40. Englberger L., Suri R.M., Li Z., Casey E.T., Daly R.C., Dearani J.A., et al. Clinical accuracy of RIFLE and acute kidney injury network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011, 15:R15-R16.
41. Bandeali S.J., Kayani W.T., Lee V.V., Pan W., Elayda M.A., Nambi V., et al. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol 2012, 110(7):919-923.
42. Benedetto U., Sciarretta S., Roscitano A., Fiorani B., Refice S., Angeloni E., et al. Preoperative angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg 2008, 86:1160-1165.
43. Yoo Y.C., Youn Y.N., Shim J.K., Kim J.C., Kim N.Y., Kwak Y.L. Effects of renin-angiotensin system inhibitors on the occurrence of acute kidney injury following off-pump coronary artery bypass grafting. Circ J 2010, 74:1852-1858.
44. Shi P., Li Z., Young N., Ji F., Wang Y., Moore P., et al. The effects of preoperative renin-angiotensin system inhibitors on outcomes in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2013, 27(4):703-709.
45. Arora P., Rajagopalam S., Ranjan R., Kolli H., Singh M., Venuto R., et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008, 3:1266-1273.
46. Barodka V., Silvestry S., Zhao N., Jiao X., Whellan D.J., Diehl J., et al. Preoperative renin-angiotensin system inhibitors protect renal function in aging patients undergoing cardiac surgery. J Surg Res 2011, 167(2):e63-e69.
47. Yacoub R., Patel N., Lohr J.W., Rajagopalan S., Nader N., Arora P. Acute kidney injury and death associated with renin angiotensin system blockade in cardiothoracic surgery: a meta-analysis of observational studies. Am J Kidney Dis 2013, 62(6):1077-1086.
48. Coca S.G., Garg A.X., Swaminathan M., Garwood S., Hong K., Thiessen-Philbrook H., et al. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 2013, 28(11):2787-2799.
49. Anne W., Willems R., Merwe N.V., Werf F.V., Ector H., Heidbüchel H. Atrial fibrillation after radiofrequency ablation of atrial flutter: preventive effect of angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and diuretics. Heart 2004, 90:1025-1030.
50. Dostal D.E. Regulation of cardiac collagen: angiotensin and cross-talk with local growth factors. Hypertension 2001, 37:841-844.
51. Hanna N., Cardin S., Leung T.K., Nattel S. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Cardiovasc Res 2004, 63:236-244.
52. Xiao H.D., Fuchs S., Campbell D.J., Lewis W., Dudley S.C., Kasi V.S., et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 2004, 165:1019-1032.
53. De Mello W.C. Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes. Hypertension 1998, 32:976-982.
54. Ferron L., Capuano V., Ruchon Y., Deroubaix E., Coulombe A., Renaud J.F. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circ Res 2003, 93:1241-1248.
55. Fareh S., Benardeau A., Thibault B., Nattel S. The T-type Ca(2{thorn}) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 1999, 100:2191-2197.
56. Shinagawa K., Mitamura H., Ogawa S., Nattel S. Effects of inhibiting Na({thorn})/H({thorn})-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling. Cardiovasc Res 2002, 54:438-446.
57. Daleau P., Turgeon J. Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes. Pflugers Arch 1994, 427:553-555.
58. Van der Harst P., Volbeda M., Voors A.A. Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting. Hypertension 2004, 44:930-934.
59. Ozaydin M., Dogan A., Varol E., Kapan S., Tuzun N., Peker O., et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2006, 107:117-121.
60. Dahlöf B., Devereux R.B., Kjeldsen S.E., Julius S., Beevers G., de Faire U., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359(9311):995-1003.
61. Madrid A.H., Peng J., Zamora J., Marín I., Bernal E., Escobar C., et al. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials. Pacing Clin Electrophysiol 2004, 27(10):1405-1410.
62. Ozaydin M., Dede O., Varol E., Kapan S., Turker Y., Peker O., et al. Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation. Int J Cardiol 2008, 127(3):362-367.
63. Chin J.H., Lee E.H., Son H.J., Kim W.J., Choi D.K., Park S.K., et al. Preoperative treatment with an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker has no beneficial effect on the development of new-onset atrial fibrillation after off-pump coronary artery bypass graft surgery. Clin Cardiol 2012, 35(1):37-42.
64. White C.M., Kluger J., Lertsburapa K., Faheem O., Coleman C.I. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg 2007, 31(5):817-820.